Advertisement
Research Article

Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis

  • Dick Menzies mail,

    Dick.Menzies@mcgill.ca

    Affiliation: Respiratory and Epidemiology Clinical Research Unit, Montreal Chest Institute, McGill University, Montreal, Canada

    X
  • Andrea Benedetti,

    Affiliation: Respiratory and Epidemiology Clinical Research Unit, Montreal Chest Institute, McGill University, Montreal, Canada

    X
  • Anita Paydar,

    Affiliation: Respiratory and Epidemiology Clinical Research Unit, Montreal Chest Institute, McGill University, Montreal, Canada

    X
  • Sarah Royce,

    Affiliation: University of California at San Francisco, San Francisco, California, United States of America

    X
  • Madhukar Pai,

    Affiliation: Respiratory and Epidemiology Clinical Research Unit, Montreal Chest Institute, McGill University, Montreal, Canada

    X
  • William Burman,

    Affiliation: Denver Public Health, Denver, Colorado, United States of America

    X
  • Andrew Vernon,

    Affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

    X
  • Christian Lienhardt

    Affiliation: International Union against Tuberculosis and Lung Diseases, and Institut de Recherche pour le Développement, Paris, France

    X
  • Published: September 15, 2009
  • DOI: 10.1371/journal.pmed.1000150

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis

Dick Menzies, Andrea Benedetti, Anita Paydar, Ian Martin, Sarah Royce, Madhukar Pai, Andrew Vernon, Christian Lienhardt, William Burman
Research Article | published 15 Sep 2009 | PLOS Medicine
doi:10.1371/journal.pmed.1000146